ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

NMC Nmc Health Plc

938.40
0.00 (0.00%)
24 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Nmc Health Plc LSE:NMC London Ordinary Share GB00B7FC0762 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 938.40 940.00 941.60 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

NMC Health Plc Notice of Results (1184Y)

01/03/2017 7:01am

UK Regulatory


Nmc Health (LSE:NMC)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Nmc Health Charts.

TIDMNMC

RNS Number : 1184Y

NMC Health Plc

01 March 2017

NMC Health plc to Report Full Year 2016 Results on 8 March 2017

London, 1 March 2017: NMC Health plc (the "Company") will report its full year 2016 financial results (for the twelve months to 31 December 2016) on Wednesday, 8 March 2017.

The results are expected to be published on the Regulatory News Service at 7am UK time on that day, and shortly thereafter on the Company's website at http://www.nmchealth.com/investor-relations/.

Dial-in details for a conference call for analysts and investors will be circulated in due course.

Contacts

NMC

 
 Prasanth Manghat, Deputy 
  Chief Executive Officer        +971 (0)50 522 5648 
 Suresh Krishnamoorthy, Chief 
  Financial Officer              +971 (0)50 591 5365 
 Roy Cherry, Head of Strategy 
  & Investor Relations           +971 (0)50 667 0184 
 

Media

FTI Consulting, London

 
 Matthew Cole    +44 (0)20 3727 1101 
 

FTI Consulting, Gulf

 
 Shane Dolan    +971 (0)4 437 2100 
 

About NMC Health

The Group is the leading private sector healthcare operator in the United Arab Emirates, with a nation-wide network of hospitals and operations in the country since 1975. The Group currently operates or manages eight hospitals, two day-care patient centres, nine medical centres and fifteen pharmacies. In addition, the Group owns and operates Clinica Eugin in Barcelona, Spain - one of the leading fertility treatment centres globally. NMC also owns 51 per cent. shareholding in Fakih IVF Group, the Middle East market leader for in-vitro fertilisation ("IVF") services. Moreover, NMC also owns and operates Americare Group, the leading home care provider in the UAE as well as ProVita, the pioneering provider of long-term medical care, also in the UAE. The enlarged company received almost 3.2 million patients in 2015. The Group is also a leading UAE supplier of products and consumables across several key market segments, with the major contribution coming from healthcare related products. The Group reported revenues of US$880.9 million for the year ended 31 December 2015.

In April 2012 NMC was listed on the Premium Segment of the London Stock Exchange. NMC is a constituent of the FTSE 250 Index.

This information is provided by RNS

The company news service from the London Stock Exchange

END

NORUWRBRBSAUUAR

(END) Dow Jones Newswires

March 01, 2017 02:01 ET (07:01 GMT)

1 Year Nmc Health Chart

1 Year Nmc Health Chart

1 Month Nmc Health Chart

1 Month Nmc Health Chart

Your Recent History

Delayed Upgrade Clock